PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover a mechanism that could improve platinum-based cancer therapy

Targeting a protein in bladder cancer could increase patient eligibility for platinum-based therapies, as well as make this treatment more effective.

2024-03-27
(Press-News.org) AURORA, Colo. (March 27, 2024) – Researchers have identified a protein that, when targeted, enables cisplatin-resistant cancer cells to become responsive to treatment. Cisplatin, and other similar platinum drugs, are incredibly effective at killing rapidly growing cancer cells, which is why they have been used in treating cancers for over 45 years. However, these drugs are non-targeted and can cause debilitating toxic side effects, resulting in a diminished lifestyle, and patients in poor health are deemed ineligible for use.

In a study, published today in Cancer Research, a journal of the American Association for Cancer Research, researchers say they have discovered that the protein puromycin-sensitive aminopeptidase (NPEPPS) plays a role in regulating response to platinum chemotherapy in patients with bladder cancer.

“We found that this protein is a driver in resistance to platinum therapy. If we remove it experimentally or pharmacologically, we can re-sensitize the cancer cells to their pre-resistant level of response,” says James Costello, PhD, co-corresponding author and associate professor at the University of Colorado Anschutz Medical Campus.

Costello and co-authors aimed to understand why most bladder cancer patients do not respond well to platinum-based drug regimens. By identifying the role NPEPPS plays, researchers were then able to genetically disrupt the function of NPEPPS, ultimately making cancer cells more responsive to platinum drugs.

“Our multi-omic assessment, including the use of tiny organoids derived from patients’ bladder cancer samples, yielded findings that could make this effective treatment an option for many more patients,” said Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer, the PHASE ONE Foundation Distinguished Chair at Cedars-Sinai and co-corresponding author of the study.

Theodorescu added that the approach is an example of how precision medicine is leading the change in how cancer is treated by defining cancer vulnerabilities such as NPEPPS that can be targeted with small molecules and used in combination with cisplatin. Indeed, the Theodorescu and Costello laboratories are doing just that.

“This novel therapeutic approach could allow the administration of lower platinum drug doses, potentially decreasing debilitating side effects while also making platinum-based therapies more effective,” says Costello, also with the CU Cancer Center. He points to next steps in utilizing this new approach in hopes of expanding its use to other cancers.

“A high percentage of all cancer patients will see a platinum drug in their treatment. Our work opens the door for extending these findings to other cancer types. Our goal is to help platinum-based agents be more effective in many clinical settings.”

 

About the University of Colorado Anschutz Medical Campus

The University of Colorado Anschutz Medical Campus is a world-class medical destination at the forefront of transformative science, medicine, education and patient care. The campus encompasses the University of Colorado health professional schools, more than 60 centers and institutes, and two nationally ranked independent hospitals - UCHealth University of Colorado Hospital and Children's Hospital Colorado - that treat more than two million adult and pediatric patients each year. Innovative, interconnected and highly collaborative, the University of Colorado Anschutz Medical Campus delivers life-changing treatments, patient care and professional training and conducts world-renowned research fueled by over $705 million in research grants. For more information, visit www.cuanschutz.edu.

 

###

END



ELSE PRESS RELEASES FROM THIS DATE:

Memory self-test via smartphone can identify early signs of Alzheimer’s disease

2024-03-27
Dedicated memory tests on smartphones enable the detection of “mild cognitive impairment”, a condition that may indicate Alzheimer’s disease, with high accuracy. Researchers from DZNE, the Otto-von-Guericke University Magdeburg and the University of Wisconsin-Madison in the United States who collaborated with the Magdeburg-based company “neotiv” report these findings in the scientific journal npj Digital Medicine. Their study is based on data from 199 older adults. The results underline the potential of mobile apps for Alzheimer’s disease research, clinical trials and routine medical care. The app that ...

New enzymatic cocktail can kill tuberculosis-causing mycobacteria

2024-03-27
Washington, D.C.—With resistance to chemical antibiotics on the rise, the world needs entirely new forms of antibiotics. A new study published in Microbiology Spectrum, a journal of the American Society for Microbiology, shows that an enzymatic cocktail can kill a variety of mycobacterial species of bacteria, including those that cause tuberculosis. The research was carried out by scientists at Colorado State University and Endolytix Technologies. “We have a mycobacterial drug that works for Nontuberculous Mycobacteria and M. tuberculosis that is biological, not phage therapy, and not small molecule antibiotics,” said Jason Holder, Ph.D., a study coauthor ...

Popular obesity drugs may lead to medical procedure complications

2024-03-27
New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications. Investigators found glucagon-like peptide-1 receptor agonists (GLP-1RAs) —medications like Ozempic and Wegovy that are used to treat diabetes and obesity—are associated with an increased risk of aspiration pneumonia following endoscopy. The large, population-based study is published in the leading ...

USDA completes laboratory modernization to advance pecan breeding and research

2024-03-27
SOMERVILLE, TEXAS, March 27, 2024- The Pecan Breeding and Genetics Program of the U.S. Department of Agriculture's Agricultural Research Service (USDA-ARS) recently completed a $2.5 million laboratory modernization to accelerate pecan breeding through innovations in genetics and plant disease research. A ribbon-cutting ceremony was held on March 26 to commemorate the completion of the project. Pecan trees represent North America's native nut tree and a multimillion-dollar crop. These trees have been cultivated commercially for less than 150 years. It takes an average of 28 years from planting ...

Liver fibrosis, non-parenchymal cells, and the promise of exosome therapy

Liver fibrosis, non-parenchymal cells, and the promise of exosome therapy
2024-03-27
Liver disease is a major health concern, causing millions of deaths worldwide each year. One serious complication is liver fibrosis, scarring that can lead to liver failure. There is currently no effective treatment, but new research suggests promise for exosomes, tiny sacs released by cells. Non-parenchymal cells like hepatic stellate cells (HSCs), Kupffer cells (KCs), and liver sinusoidal endothelial cells (LSECs) play a key role in fibrosis development. These cells are involved in inflammation, scar formation, and tissue repair. Understanding ...

Highest power efficiency achieved in flexible solar cells using new fabrication technique

Highest power efficiency achieved in flexible solar cells using new fabrication technique
2024-03-27
Flexible solar cells have many potential applications in aerospace and flexible electronics, but low energy conversion efficiency has limited their practical use. A new manufacturing method has increased the power efficiency of flexible solar cells made from perovskite, a class of compounds with a specific crystalline structure that facilitates the conversion of solar energy into electricity.   Current flexible perovskite solar cells (FPSCs) suffer from lower power conversion efficiency than ...

Astronomers unveil strong magnetic fields spiraling at the edge of Milky Way’s central black hole

Astronomers unveil strong magnetic fields spiraling at the edge of Milky Way’s central black hole
2024-03-27
A new image from the Event Horizon Telescope (EHT) collaboration— which includes scientists from the Center for Astrophysics | Harvard & Smithsonian (CfA)— has uncovered strong and organized magnetic fields spiraling from the edge of the supermassive black hole Sagittarius A* (Sgr A*). Seen in polarized light for the first time, this new view of the monster lurking at the heart of the Milky Way Galaxy has revealed a magnetic field structure strikingly similar to that of the black hole at the center of the M87 galaxy, suggesting that strong magnetic fields may be common to all black holes. This similarity also hints toward a hidden ...

Your genes may raise your heart attack risk during high-stress times

2024-03-27
People with specific genetic traits and those who have anxiety or depression have a significantly higher heart attack risk during periods of social or political stress than at other times, according to a new study being presented at the American College of Cardiology’s Annual Scientific Session. Researchers said the findings suggest opportunities to identify those at elevated risk and perhaps even prevent cardiac events. Doctors have long noticed that heart attacks tend to spike around certain times, such as the winter holidays, but the reasons ...

ADHD stimulants may increase risk of heart damage in young adults

2024-03-27
Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder (ADHD) were significantly more likely to develop cardiomyopathy (weakened heart muscle) compared with those who were not prescribed stimulants, in a study presented at the American College of Cardiology’s Annual Scientific Session. The study found that people prescribed stimulants such as Adderall and Ritalin were 17% more likely to have cardiomyopathy at one year and 57% more likely to have cardiomyopathy at eight years compared with those who were not taking these medications. Cardiomyopathy involves structural ...

Getting too little sleep linked to high blood pressure

2024-03-27
Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over time, according to a study presented at the American College of Cardiology’s Annual Scientific Session. While the association between sleep patterns and high blood pressure has been reported, evidence about the nature of this relationship has been inconsistent, according to researchers. The current analysis pools data from 16 studies conducted between January 2000 and May 2023, evaluating hypertension incidence in 1,044,035 people from six countries who did not have a prior history of high blood pressure over a median follow-up of five years (follow-up ranged from 2.4 to 18 years). ...

LAST 30 PRESS RELEASES:

The sound of traffic increases stress and anxiety

Global food yields have grown steadily during last six decades

Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study

North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabl

Higher levels of democracy and lower levels of corruption are associated with more doctors, independent of healthcare spending, per cross-sectional study of 134 countries

In major materials breakthrough, UVA team solves a nearly 200-year-old challenge in polymers

Wyoming research shows early North Americans made needles from fur-bearers

Preclinical tests show mRNA-based treatments effective for blinding condition

Velcro DNA helps build nanorobotic Meccano

Oceans emit sulfur and cool the climate more than previously thought

Nanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry

Rare, mysterious brain malformations in children linked to protein misfolding, study finds

Newly designed nanomaterial shows promise as antimicrobial agent

Scientists glue two proteins together, driving cancer cells to self-destruct

Intervention improves the healthcare response to domestic violence in low- and middle-income countries

State-wide center for quantum science: Karlsruhe Institute of Technology joins IQST as a new partner

Cellular traffic congestion in chronic diseases suggests new therapeutic targets

Cervical cancer mortality among US women younger than age 25

Fossil dung reveals clues to dinosaur success story

New research points way to more reliable brain studies

‘Alzheimer’s in dish’ model shows promise for accelerating drug discovery

Ultraprocessed food intake and psoriasis

Race and ethnicity, gender, and promotion of physicians in academic medicine

Testing and masking policies and hospital-onset respiratory viral infections

A matter of life and death

Huge cost savings from more efficient use of CDK4/6 inhibitors in metastatic breast cancer reported in SONIA study

What a gut fungus reveals about symbiosis and allergy

Insilico Medicine recognized by Endeavor Venture Group & Mount Sinai Health System with Showcase AI and Biotech Innovation Award

ESMO Asia Congress 2024: Event Announcement

The pathophysiological relationship and treatment progress of obstructive sleep apnea syndrome, obesity, and metabolic syndrome

[Press-News.org] Researchers discover a mechanism that could improve platinum-based cancer therapy
Targeting a protein in bladder cancer could increase patient eligibility for platinum-based therapies, as well as make this treatment more effective.